Quantitative systems pharmacology of HIV PrEP and PEP

Expert Opinion on Drug Metabolism and Toxicology · Published 2026-08-05 · DOI 10.1080/17425255.2026.2715711

Free full text

Authors (5)

Sara Iannuzzi, Lanxin Zhang, Antonia Liebenberg, Hee-Yeong Kim, Max von Kleist

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Iannuzzi, S., Zhang, L., Liebenberg, A., et al. (2026). Quantitative systems pharmacology of HIV PrEP and PEP. Expert Opinion on Drug Metabolism and Toxicology. https://doi.org/10.1080/17425255.2026.2715711

Related articles

• T cell immunity is key to the pandemic endgame: How to measure and monitor it · Current Research in Immunology · 2022 · Cites or is cited by this article
• Pharmacokinetics, Pharmacodynamics, Efficacy and Drug Resistance Selection of Injectable Long‐Acting Lenacapavir Pre‐Exposure Prophylaxis ( PrEP ) Against HIV · CPT: Pharmacometrics & Systems Pharmacology · 2026 · Cites or is cited by this article
• Tirabrutinib–anthracycline interactions in the brain tumor microenvironment: a focus on metabolic inactivation and resistance · Expert Opinion on Drug Metabolism and Toxicology · 2025 · Same journal
• Microbiome-driven PKs: redefining drug metabolism beyond host enzymes · Expert Opinion on Drug Metabolism and Toxicology · 2026 · Same journal
• Combined oral contraceptives and pharmacokinetic drug interactions: impact on efficacy and safety · Expert Opinion on Drug Metabolism and Toxicology · 2026 · Same journal
• Predicting the potential for organic cation transporter 1-mediated drug–drug interactions with fenoterol by amitriptyline, fluoxetine, selegiline, metformin, and verapamil · Expert Opinion on Drug Metabolism and Toxicology · 2026 · Same journal
• Pharmacokinetics and safety of the combination of KL130008 and methotrexate in rheumatoid arthritis patients: a multicenter, open-label phase Ib trial · Expert Opinion on Drug Metabolism and Toxicology · 2025 · Same journal
• Evaluation of the drug-drug interaction between low-dose methotrexate and short-term use of non-steroidal anti-inflammatory drugs · Expert Opinion on Drug Metabolism and Toxicology · 2025 · Same journal
• GLP-1RA PHARMACOKINETICS AND CLINICAL EFFECTS: FOCUS ON CARDIAC, VASCULAR, AND GLOMERULAR STRUCTURES · Expert Opinion on Drug Metabolism and Toxicology · 2026 · Same journal
• Modifying Hy’s Law and eDISH for the modern idiosyncratic DILI era · Expert Opinion on Drug Metabolism and Toxicology · 2025 · Same journal